Ventus Therapeutics is a biopharmaceutical company developing novel small molecule medicines that target the innate immune system Ventus Therapeutics is backed by investors that include GV and Versant Ventures and is headquartered in Natick.
INDUSTRY:
Biotechnology, Life Science
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
